600535:SHA
Tasly Pharmaceutical Group Co Ltd
14,01 CNY
arrow_upward
+0,07%(+0,010) 1d
8 d’oct., 15:00:02 GMT+8 · CNY
search
Tots els símbols
| Símbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadístiques principals per a 600535...
Obre
14,00 CNY
Alt
14,13 CNY
Baix
13,93 CNY
Capitalització borsària
20,92 kM
Volum mitjà
12,38 M
Volum
14,99 M
Ràtio preu-benefici
17,11
Alt 52 setmanes
16,24 CNY
Baix 52 setmanes
12,90 CNY
BPA
0,82 CNY
Accions en circulació
1512,67 M
Nombre d'empleats
11 k
Obre
14,00 CNY
Alt
14,13 CNY
Baix
13,93 CNY
Capitalització borsària
20,92 kM
Volum mitjà
12,38 M
Volum
14,99 M
Ràtio preu-benefici
17,11
Alt 52 setmanes
16,24 CNY
Baix 52 setmanes
12,90 CNY
BPA
0,82 CNY
Accions en circulació
1512,67 M
Nombre d'empleats
11 k
Accions relacionades
Notícies
De fonts web i partners de notícies
Breakingthenews.net
·
fa 9 hores
El Dow cae 500 puntos al subir el petróleo y los rendimientos
marketscreener.com
·
fa 30 minuts
US Equity Indexes Drop as Sharp Sell-Off in Semiconductor Heavyweights Sinks Technology While Crude Oil Surges
Perfil
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Sobre Tasly Pharmaceutical Group Co Ltd